Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.1T, Eli Lilly(LLY) trades at $1,165.53. The stock has a price-to-earnings ratio of 40.39 and currently yields dividends of 0.56%.
During the trading session on 2026-10-08, Eli Lilly(LLY) shares reached a daily high of $1,194.07 and a low of $1,131.21. At a current price of $1,165.53, the stock is +3.0% higher than the low and still -2.4% under the high.
Trading activity shows a volume of 3.09M, compared to an average daily volume of 2.2M.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
LLY News
Thursday, October 8, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research report...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) is running a Phase 3 trial called “A Study of Orfo...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly & Co.’s new Phase 1 trial, “A Placebo-Controlled, Single- and Multip...
Analyst ratings
84%
of 32 ratingsMore LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study “A Phase 1, Open-Label Study to Evaluate the Effect of Eloralintide...
Eli Lilly (LLY -4.54%) is trying to turn blockbuster obesity drugs into something much bigger. Its path to $1,500 depends on whether new medicines, additional i...
It’s always tempting as an investor to try to find the next big winner, and healthcare stocks have been one area where many investors are looking. The explosio...
Cantor Fitzgerald analyst Carter Gould raised the firm’s price target on Eli Lilly (LLY) to $1,440 from $1,410 and keeps an Overweight rating on the shares. Eli...
Eli Lilly received an expanded FDA approval for Jaypirca, allowing first-line use in adults with previously untreated CLL or SLL without a known 17p deletion, b...
Investing Lilly’s Worst Entry Points Were Its Most Hyped Approvals Mounjaro and Zepbound Eli Lilly's two blockbuster drug approvals that transformed the company...
Clean energy has been hot for years, but the truth is that the global economy still runs on carbon fuels like oil and natural gas. With the geopolitical conflic...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.